Author

O. Stringfield

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

K. Luddy· 1 shared L. Garcia· 1 shared M. Abdalah· 1 shared P. M. Enriquez Navas· 1 shared R. A. Gatenby· 1 shared R. J. Gillies· 1 shared S. Hassan· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

K. Luddy

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Intermittent hormonal therapy shows similar outcome than SOC in ER+ breast cancer preclinical model.

P. M. Enriquez Navas, L. Garcia, M. Abdalah, O. Stringfield, K. Luddy, S. Hassan, R. J. Gillies, R. A. Gatenby

This study shows intermittent hormonal therapy achieves similar tumor control as standard-of-care in ER+ breast cancer models with reduced drug use and preserved sensitive cell phenotypes.

bioRxiv · Jan 8, 2019 · PreprintCancer Biology